The Effect of N2O on Chronic Neuropathic Pain Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Important pharmacological agents for treatment of chronic neuropathic pain such as ketamine
block NMDA receptors. Nitrous oxide, an inhalant agent used extensively In anesthesia, also
have antagonist property of NMDA receptors. The investigators hypothesize that prolonged
treatment with N2O can alleviate chronic neuropathic pain of different causes (e.g. diabetic
neuropathy, post herpetic neuralgia etc.).